Do androgen deprivation and the biologically equivalent dose matter in low‐dose‐rate brachytherapy for intermediate‐risk prostate cancer?

The objective of this study was to investigate the impact of the biologically equivalent dose (BED) on treatment outcomes after iodine‐125 low‐dose‐rate brachytherapy (LDR‐BT) with or without supplemental external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT) for intermediate‐risk...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Med
Glavni autori: Tabata, Ryuji, Kimura, Takahiro, Kuruma, Hidetoshi, Sasaki, Hiroshi, Kido, Masahito, Miki, Kenta, Takahashi, Hiroyuki, Aoki, Manabu, Egawa, Shin
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2016
Teme:
Clinical Cancer Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5055153/
https://ncbi.nlm.nih.gov/pubmed/27456710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.820
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items